Cargando…

Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing

Detalles Bibliográficos
Autores principales:	Witjes, Vera M., Vos, Janet R., Ligtenberg, Marjolijn J.L., Hoogerbrugge, Nicoline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683677/ https://www.ncbi.nlm.nih.gov/pubmed/34977313 http://dx.doi.org/10.1016/j.gore.2021.100825

Ejemplares similares

Response to Tomao, Panici, and Tomao
por: Vos, Janet R, et al.
Publicado: (2019)

Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
por: Witjes, Vera M., et al.
Publicado: (2022)

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
por: Vos, Janet R, et al.
Publicado: (2019)

DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct
por: Sie, Aisha S, et al.
Publicado: (2012)

Universal prescription drug coverage in Canada: Long-promised yet undelivered
por: Morgan, Steven G., et al.
Publicado: (2016)

Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
por: Vogelaar, Ingrid P, et al.
Publicado: (2012)

Finding all BRCA pathogenic mutation carriers: best practice models
por: Hoogerbrugge, Nicoline, et al.
Publicado: (2016)

Achieving the promise of universal coverage – the role for strategic purchasing
por: Hanson, Kara
Publicado: (2014)

Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes–Considerations for Future Studies
por: te Paske, Iris B. A. W., et al.
Publicado: (2020)

University of Buffalo: University Extension Movement
por: Fleming, Edwin, et al.
Publicado: (1905)

Has Latin America achieved universal health coverage yet? Lessons from four countries
por: Gilardino, Ramiro E., et al.
Publicado: (2022)

Germline MUTYH gene mutations are not frequently found in unselected patients with papillary breast carcinoma
por: Boesaard, Ewout P, et al.
Publicado: (2014)

Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome
por: Vos, Janet R., et al.
Publicado: (2020)

Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
por: Elze, Lisa, et al.
Publicado: (2023)

University of Madras
por: Ganapati, C. R.
Publicado: (1945)

COVID-19 qPCR testing in women admitted for delivery in Spain: Is universal testing worthy?: A commentary
por: Cubo, A. M., et al.
Publicado: (2020)

Strengthening universal HIV ‘test-and-treat’ approaches with social science research
por: Camlin, Carol S., et al.
Publicado: (2016)

Achieving universal testing for malaria
por: Ochodo, Eleanor, et al.
Publicado: (2016)

Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
por: Sutton, Desmond, et al.
Publicado: (2020)

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011)

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes
por: Vos, Janet R., et al.
Publicado: (2018)

Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer
por: Lin, Jenny, et al.
Publicado: (2021)

Washington University of Medicine
Publicado: (1869)

Understanding Hyperlactatemia in Sepsis: Are We There Yet?
por: Nalos, Marek, et al.
Publicado: (2019)

Balanced Crystalloids in Sepsis: Are We There Yet?
por: Hammond, Drayton A., et al.
Publicado: (2020)

Are payors ready for transparent prices yet?
por: Barman-Aksözen, Jasmin
Publicado: (2022)

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)

Surveillance of women at high risk for hereditary ovarian cancer is inefficient
por: Oei, A L, et al.
Publicado: (2006)

High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling
por: Sie, Aisha S., et al.
Publicado: (2015)

What is a university education?
por: Ahmad, HR
Publicado: (2018)

Gift to University College Hospital
por: Buckle, J. Gerald
Publicado: (1924)

Bioinformatics: indispensable, yet hidden in plain sight?
por: Bartlett, Andrew, et al.
Publicado: (2017)

Dalbavancin for Staphylococcus aureus Bacteremia: Are We There Yet?
por: Mahatanan, Rattanaporn, et al.
Publicado: (2023)

PTEN Hamartoma Tumor Syndrome and Immune Dysregulation()()()
por: Eissing, Marc, et al.
Publicado: (2018)

Gynecological problems and the health of University Students
Publicado: (2019)

Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India
por: Waghmare, Rakesh, et al.
Publicado: (2021)

The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome
por: Hoxhaj, Alma, et al.
Publicado: (2022)

There is no place (yet) for routine administration of sildenafil to patients with ARDS
por: Cornet, Alexander D., et al.
Publicado: (2010)

The Case Against Exchange Transfusion Has Yet to Be Proved
por: Koh, Gavin C. K. W., et al.
Publicado: (2014)

Reinfection after COVID vaccination - The challenge is not yet over
por: Ahmed, Shanila, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_461btmeo7ph2qj025ff8b2clnj